Azenta AZTA 深沪

等待开盘 10-08 09:30:00 美东时间

35.89

-3.460

-8.79%

华盛通

立即下载

最高39.105
今开38.33
成交量 169.03万股
最低 35.555
昨收 39.35
总市值 15.72亿
52周最高 46.41
市盈率 ^静 --
换手率 3.86%
52周最低 15.93
委比 -74.59%
总股本 4380.84万
历史最高 124.69
量比 0.83
振幅 9.02%
历史最低 3.92
每手 1
风险率 5.92%

个股概要

财务分析

公司资料

分红派息

分时图
日k
周k
月k

相关新闻

Azenta shutting three Multiomics lab sites under restructuring plan

Azenta (AZTA) on Wednesday announced plans to close three lab sites operating within its Multiomics segment in North America as part of a restructuring initiative to streamline operations and improve ...

10-07 21:25
Azenta Restructures Multiomics Segment With Lab Closures

An update from Azenta ( ($AZTA) ) is now available. On October 5, 2026, Azenta’...

10-07 20:29
Applied Digital, Bitdeer Technologies, ON Semiconductor And Other Big Stocks Moving Higher On Friday

U.S. stocks were higher, with the Dow Jones index gaining over 300 points on Friday. Shares of Applied Digital Corp (NASDAQ:APLD) rose sharply after the company announced it brought an additional 75 MW of AI infrastructure online at its Polaris Forge 1 campus. Applied Digital achieved Ready for Serv...

10-02 22:47
美股大行评级 | 机构看淡消费股！麦当劳、耐克、卡夫亨氏齐遭降目标价；能源股获齐声唱多

今日重点评级关注：Ascendiant Capital：维持SurgePays"买入"评级，目标价从3.5美元升至3.75美元；HC Wainwright & Co.：维持Spero Therapeutics"买入"评级，目标价从5美元升至6美元

09-15 15:30
Needham Reiterates Buy on Azenta, Maintains $37 Price Target

Needham analyst David Saxon reiterates Azenta (NASDAQ:AZTA) with a Buy and maintains $37 price target.

09-14 22:01
Azenta completes B Medical divestiture as Thelema repays vendor loan

Life sciences company Azenta (AZTA) on Friday announced that it completed the divestiture of its B Medical Systems after Thelema S.à r.l., which acquired the medical refrigeration devices maker in Jul...

09-04 22:43
Azenta Appoints Martin Madaus Interim President, CEO; Co. Reiterates Q4 Revenue Outlook

Azenta, Inc. (Nasdaq: AZTA) ("Azenta" or "the Company") today announced that current member of the Board of Directors (the "Board") Dr. Martin Madaus has been appointed interim President and CEO, and that John Marotta has resigned as an executive officer and director of the Company. Additionally, th...

08-24 20:06
AZENTA ANNOUNCES LEADERSHIP TRANSITION

Current Director Dr. Martin Madaus Appointed Interim CEO Company Reaffirms Previously Announced Fourth Quarter Fiscal 2026 Total Revenue Guidance BURLINGTON, Mass., Aug. 24, 2026 /PRNewswire...

08-24 20:00
财报速睇 | Azenta, Inc. 2026财年Q2营收1.61亿美元，同比增长12.0%；归母净利润0.02亿美元，扭亏为盈

华盛资讯8月7日讯，Azenta, Inc.公布2026财年Q2业绩，公司Q2营收1.61亿美元，同比增长12.0%，归母净利润0.02亿美元，扭亏为盈。

08-07 11:19
美股大行评级 | AMD、Arista Networks、Booking 、加特纳、Pinterest、科力斯、Wayfair等获多家大行上调目标价

今日重点评级关注：HC Wainwright & Co.：维持Precigen"买入"评级，目标价从14美元升至18美元；HC Wainwright & Co.：维持Sophia Genetics"买入"评级，目标价从12美元升至14美元

08-06 11:36

派息除权日	每股总股息	派息日期
2021-12-02	0.10	2021-12-23
2021-09-02	0.10	2021-09-24
2021-06-03	0.10	2021-06-25
2021-03-04	0.10	2021-03-26
2020-12-03	0.10	2020-12-17
2020-09-03	0.10	2020-09-25
2020-06-04	0.10	2020-06-26
2020-03-05	0.10	2020-03-27
2019-12-05	0.10	2019-12-20
2019-09-05	0.10	2019-09-27
2019-06-06	0.10	2019-06-28
2019-02-28	0.10	2019-03-22
2018-12-06	0.10	2018-12-20
2018-09-06	0.10	2018-09-28
2018-05-31	0.10	2018-06-22
2018-03-01	0.10	2018-03-23
2017-11-30	0.10	2017-12-22
2017-09-07	0.10	2017-09-29
2017-05-31	0.10	2017-06-23
2017-03-01	0.10	2017-03-24
2016-11-30	0.10	2016-12-23
2016-08-31	0.10	2016-09-23
2016-06-01	0.10	2016-06-24
2016-03-02	0.10	2016-03-24
2015-12-02	0.10	2015-12-22
2015-09-02	0.10	2015-09-25
2015-06-03	0.10	2015-06-26
2015-03-04	0.10	2015-03-27
2014-12-03	0.10	2014-12-26
2014-09-03	0.10	2014-09-26
2014-06-04	0.08	2014-06-27
2014-03-05	0.08	2014-03-28
2013-12-04	0.08	2013-12-27
2013-09-04	0.08	2013-09-27
2013-06-05	0.08	2013-06-28
2013-03-06	0.08	2013-03-29
2012-12-05	0.08	2012-12-28
2012-09-05	0.08	2012-09-28
2012-06-06	0.08	2012-06-29
2012-03-07	0.08	2012-03-30
2011-12-07	0.08	2011-12-30
2011-09-07	0.08	2011-09-30

公司名称	Azenta, Inc.
行业分类	Medical/Nursing Services
业务描述	Azenta, Inc. is a global provider of life sciences solutions, enabling organizations worldwide to bring impactful breakthroughs and therapies to market faster. The company offers a suite of reliable cold-chain sample management solutions and multiomics services supporting drug development, clinical research, and advanced cell therapies for pharmaceutical, biotechnology, academic, and healthcare institutions globally. It operates through the following segments: Sample Management Solutions and Multiomics. The Sample Management Solutions segment provides end-to-end sample management products and services, including Sample Repository Services (SRS). Its core products include automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled-rate thawing devices. The Multiomics segment delivers genomic and other sample analysis services, including gene sequencing, gene synthesis, and related services. The company was founded in 1978 and is headquartered in Burlington, MA.

Azenta AZTA 深 沪

35.89

个股概要

财务分析

公司资料

相关新闻

分红派息

相关新闻

公司简介

Azenta AZTA 深沪